Ligularia fischeri inhibits endothelial cell proliferation, invasion and tube formation through the inactivation of mitogenic signaling pathways and regulation of vascular endothelial cadherin distribution and matrix metalloproteinase expression

Jae Hyeon Kim, Hyeonju Kim, Jinkyu Kim, Eun‐Kyung Ahn, Hyejin Ko, Young‐Rak Cho, Sang-Jin Lee, Gyu‐Un Bae, Yong Kee Kim, Jong Woo Park, Joa Sub Oh, Dong Wan SeoOncology 2015 · DOI

Introduction

Angiogenesis, the formation of new blood vessels from pre-existing ones, is a fundamental biological process. While essential for normal development and wound healing, it is also a critical "hallmark of cancer," as tumors require a robust blood supply to grow beyond a few millimeters and metastasize. Researchers are increasingly looking toward ethnopharmacology—traditional medicine—to find safer, multi-targeted alternatives to current synthetic anti-angiogenic drugs, which often carry significant side effects.

This study investigates the ethanolic extract of Ligularia fischeri (LF), an edible herb used in Eastern Asia for treating inflammatory and infectious diseases. The research explores how LF modulates the behavior of human umbilical vein endothelial cells (HUVECs), specifically focusing on its ability to inhibit proliferation, invasion, and tube formation.

The Challenge of Pathological Angiogenesis

Many current anti-angiogenic therapies, such as Matrix Metalloproteinase (MMP) inhibitors, have faced challenges in clinical trials due to limited efficacy and severe side effects like musculoskeletal pain. The complexity of angiogenic signaling means that targeting a single pathway often allows cells to find "workarounds." LF offers a potential solution by acting as a "molecular shotgun," simultaneously hitting multiple signaling nodes required for vessel growth.

Experimental Approach

The study utilized HUVECs as a primary model for human vascular biology. The researchers employed several key techniques to dissect LF's effects:

  • Cell Cycle Analysis: Tracking DNA content to determine how LF affects cell division.
  • Western Blotting: Quantifying the expression and activation (phosphorylation) of proteins involved in growth signaling and structural remodeling.
  • Functional Assays: Transwell invasion and tube formation assays were used to mimic the physical processes of vessel sprouting and organization.
  • Immunofluorescence: Visualizing the distribution of VE-cadherin, the "glue" that maintains endothelial cell-cell contacts.

Molecular Mechanisms of LF Action

LF's anti-angiogenic activity is driven by three primary mechanisms:

  1. Cell Cycle Arrest: LF induces a "stop sign" at the G1 phase. It achieves this by upregulating the inhibitor protein p27Kip1 and downregulating cyclin-dependent kinases (Cdks) and cyclins, leading to the hypophosphorylation of the retinoblastoma protein (pRb).
  2. Signaling Shutdown: The extract inactivates several major mitogenic pathways simultaneously, including ERK, Akt, p70S6K, and p38MAPK. This broad inhibition prevents the cells from receiving the signals necessary to migrate and multiply.
  3. Structural Stabilization and Matrix Control: LF prevents the loss of VE-cadherin at cell junctions, keeping the endothelial layer intact. Simultaneously, it downregulates MMP-2 and MMP-9, the enzymes cells use to digest the extracellular matrix during invasion.

Key Results: Cell Cycle Arrest and Signaling Shutdown

The study demonstrated that LF treatment significantly modulates the molecular machinery of the cell cycle. As shown in the data below, adding LF to mitogen-stimulated cells (Complete Media, CM) leads to a measurable increase in the G1 phase population and a corresponding decrease in the expression of growth-promoting proteins.

Figure 7: LF induces G1 phase arrest and modulates cell cycle regulatory proteins. (A) Flow cytometry analysis showing a shift from 63.8% to 69.8% in G1 phase upon LF treatment. (B) Western blot analysis demonstrating reduced Cdk/cyclin levels and pRb phosphorylation.

Specifically, LF suppressed HUVEC proliferation in a dose-dependent manner without causing direct cytotoxicity. In functional tests, LF almost entirely blocked the ability of cells to form branching vascular networks (tube formation) and significantly reduced their invasive capacity.

Future Directions

While these in vitro results are promising, the study's primary limitation is the lack of in vivo data. The complex environment of a living organism—including blood flow and immune interactions—may influence LF's efficacy. Future research should focus on identifying the specific bioactive molecules within the extract (such as ethyl caffeate) and testing them in animal tumor models to confirm their potential as therapeutic agents for angiogenesis-related disorders.

Summary updated

Abstract

Ligularia fischeri (LF) has been used as an edible herb and traditional medicine for the treatment of inflammatory and infectious diseases. In the present study, we report the effects and molecular mechanism of the ethanolic extract of LF on cell proliferation, invasion and tube formation in human umbilical vein endothelial cells (HUVECs). LF-mediated inhibition of cell proliferation was accompanied by reduced expression of cell cycle-related proteins such as cyclin-dependent kinases (Cdks) and cyclins, leading to pRb hypophosphorylation and G1 phase cell cycle arrest. We also show that LF treatment inhibited cell invasion and tube formation in HUVECs. These anti-angiogenic activities of LF were associated with the inactivation of mitogenic signaling pathways, induction of vascular endothelial (VE)-cadherin distribution at cell-cell contacts and inhibition of matrix metalloproteinase (MMP) expression. Collectively, our findings demonstrate the pharmacological functions and molecular mechanisms of LF in regulating endothelial cell fates, and support further development as a potential therapeutic agent for the treatment and prevention of angiogenesis-related disorders including cancer.
BibTeX
@inproceedings{kim2015ligularia,
  author = {Jae Hyeon Kim and Hyeonju Kim and Jinkyu Kim and Eun‐Kyung Ahn and Hyejin Ko and Young‐Rak Cho and Sang-Jin Lee and Gyu‐Un Bae and Yong Kee Kim and Jong Woo Park and Joa Sub Oh and Dong Wan Seo},
  title = {{Ligularia fischeri inhibits endothelial cell proliferation, invasion and tube formation through the inactivation of mitogenic signaling pathways and regulation of vascular endothelial cadherin distribution and matrix metalloproteinase expression}},
  booktitle = {Oncology},
  year = {2015},
  doi = {10.3892/or.2015.4000},
}
Figure